• Biomedical Science Letters
• /
• v.26 no.3
• /
• pp.127-135
• /
• 2020

Coronavirus is generally known to cause minor respiratory diseases in animals and humans. However, some coronavirus genus is reported to cause animal-to-human interspecies infection. Since the end of 2019, a new type of coronavirus (COVID-19) infection is spreading rapidly throughout the world, leading to the declaration of the pandemic by the World Health Organization (WHO). Despite various clinical studies to counter COVID-19 infection, the total confirmed cases and death rates are still accumulating. To break down this new threat, we should pay attention to newly revealed information based on scientific facts. In this review, we introduced the clinical characteristics, diagnostic methods, and treatment of patients infected with COVID-19. Moreover, we highlighted the correlation between COVID-19 severity and patients with underlying diseases. Potential risks associated with COVID-19 can be differed depending on the condition of patients and can cause pulmonary complications. Therefore, lung capacity exams are expected to help predict the progression of the disease along with previously established detection methods such as molecular diagnostics and immunoassay. Although physiological research hasn't yet been emphasized to evaluate COVID-19 infection, this review is expected to be valuable to give new inspiration to deal with COVID-19 which might strike again in the future.

• International Journal of Computer Science & Network Security
• /
• v.22 no.9
• /
• pp.149-158
• /
• 2022

The pandemic of Covid-19 (Coronavirus Disease 19) has devastated the world, affected millions of people, and disrupted the world economy. The cause of the Covid19 epidemic has been identified as a new variant known as Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV2). It motives irritation of a small air sac referred to as the alveoli. The alveoli make up most of the tissue in the lungs and fill the sac with mucus. Most human beings with Covid19 usually do no longer improve pneumonia. However, chest x-rays of seriously unwell sufferers can be a useful device for medical doctors in diagnosing Covid19-both CT and X-ray exhibit usual patterns of frosted glass (GGO) and consolidation. The introduction of deep getting to know and brand new imaging helps radiologists and medical practitioners discover these unnatural patterns and pick out Covid19-infected chest x-rays. This venture makes use of a new deep studying structure proposed to diagnose Covid19 by the use of chest X-rays. The suggested model in this work aims to predict and forecast the patients at risk and identify the primary COVID-19 risk variables

• Archives of Plastic Surgery
• /
• v.49 no.5
• /
• pp.611-613
• /
• 2022

The coronavirus disease 2019 (COVID-19) pandemic has been challenging in all aspects of the medical field with new clinical presentations constantly arising. Plastic surgeons are not immune to this and need to be aware of their implications. There has been a recent report of late periprosthetic seroma (breast implant) as a clinical manifestation of COVID-19 infection. To our knowledge, this phenomenon has not been further reported. We present a 53-year-old immunocompromised lady who developed late seroma after COVID-19 infection. She eventually required explantation of the implant and is awaiting autologous reconstruction. It is likely that we will increasingly continue to see this phenomenon of implant complications as a result of COVID-19 infection and should be watchful, especially regarding potential immunocompromised patients.

• Journal of Yeungnam Medical Science
• /
• v.39 no.2
• /
• pp.89-97
• /
• 2022

More than 2 years after the explosion of the coronavirus disease 2019 (COVID-19) pandemic, extensive efforts have been made to develop safe and efficacious vaccines against infections with severe acute respiratory syndrome coronavirus 2. The pandemic has opened a new era of vaccine development based on next-generation platforms, including messenger RNA (mRNA)-based technologies, and paved the way for the future of mRNA-based therapeutics to provide protection against a wide range of infectious diseases. Multiple vaccines have been developed at an unprecedented pace to protect against COVID-19 worldwide. However, important knowledge gaps remain to be addressed, especially in terms of how vaccines induce immunogenicity and efficacy in those who are elderly. Here, we discuss the various vaccine platforms that have been utilized to combat COVID-19 and emphasize how these platforms can be a powerful tool to react quickly to future pandemics.

• International Journal of Computer Science & Network Security
• /
• v.24 no.1
• /
• pp.156-162
• /
• 2024

Humanity has gone since a long time through several pandemics; we cite H1N1 in 2009 and also Spanish flu in 1917. In December 2019, the health authorities of China detected unexplained cases of pneumonia. The WHO (World Health Organization) has declared the apparition of Covid-19 (novel Coronavirus). In data analysis, multiple approaches and diverse techniques were used to extract useful information from multiple heterogeneous sources and to discover knowledge and new information for decision-making. In this paper, we propose a multidimensional model for analyzing the Coronavirus Covid-19 data (spread and vaccination in European countries).

• Journal of Microbiology and Biotechnology
• /
• v.32 no.1
• /
• pp.1-5
• /
• 2022

Diagnostics, vaccines, and drugs are indispensable tools and control measures employed to overcome infectious diseases such as coronavirus disease 2019 (COVID-19). Diagnostic tools based on RT-PCR were developed early in the COVID-19 pandemic and were urgently required for quarantine (testing, tracing and isolation). Vaccines such as mRNA vaccines and virus-vectored vaccines were also successfully developed using new platform technologies within one year after identifying severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as the causative agent of COVID-19. Drug development has been conducted in various ways including drug repurposing, convalescent plasma therapy, and monoclonal antibody development. Among the above efforts, this review examines COVID-19 drug development along with the related and upcoming challenges.

• IMMUNE NETWORK
• /
• v.21 no.1
• /
• pp.4.1-4.18
• /
• 2021

The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human health, economy, and social life worldwide. As a counteraction for this devastating disease, a number of vaccines are being developed with unprecedented speed combined with new technologies. As COVID-19 vaccines are being developed in the absence of a licensed human coronavirus vaccine, there remain further questions regarding the long-term efficacy and safety of the vaccines, as well as immunological mechanisms in depth. This review article discusses the current status of COVID-19 vaccine development, mainly focusing on antigen design, clinical trials in later stages, and immunological considerations for further study.

• Clinical and Experimental Pediatrics
• /
• v.64 no.2
• /
• pp.68-75
• /
• 2021

The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been spreading worldwide since December 2019. Hundreds of cases of children and adolescents with Kawasaki disease (KD)-like hyperinflammatory illness have been reported in Europe and the United States during the peak of the COVID-19 pandemic with or without shock and cardiac dysfunction. These patients tested positive for the polymerase chain reaction or antibody test for SARS-CoV-2 or had a history of recent exposure to COVID-19. Clinicians managing such patients coined new terms for this new illness, such as COVID-19-associated hyperinflammatory response syndrome, pediatric inflammatory multisystem syndrome temporally associated with COVID-19, or COVID-19-associated multisystem inflammatory syndrome in children (MIS-C). The pathogenesis of MIS-C is unclear; however, it appears similar to that of cytokine storm syndrome. MIS-C shows clinical features similar to KD, but differences between them exist with respect to age, sex, and racial distributions and proportions of patients with shock or cardiac dysfunction. Recommended treatments for MIS-C include intravenous immunoglobulin, corticosteroids, and inotropic or vasopressor support. For refractory patients, monoclonal antibody to interleukin-6 receptor (tocilizumab), interleukin-1 receptor antagonist (anakinra), or monoclonal antibody to tumor necrosis factor (infliximab) may be recommended. Patients with coronary aneurysms require aspirin or anticoagulant therapy. The prognosis of MIS-C seemed favorable without sequelae in most patients despite a reported mortality rate of approximately 1.5%.

• IMMUNE NETWORK
• /
• v.21 no.1
• /
• pp.1.1-1.16
• /
• 2021

The emergence of a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has become a significant health concern worldwide. Undoubtedly, a better understanding of the innate and adaptive immune responses against SARS-CoV-2 and its relationship with the coronavirus disease 2019 (COVID-19) pathogenesis will be the sole basis for developing and applying therapeutics. This review will summarize the published results that relate to innate immune responses against infections with human coronaviruses including SARS-CoV-1 and SARS-CoV-2 in both humans and animal models. The topics encompass the innate immune sensing of the virus to the dysregulation of various innate immune cells during infection and disease progression.

• The Korean Journal of Food & Health Convergence
• /
• v.7 no.5
• /
• pp.19-31
• /
• 2021

The purpose of this study is to examine whether there is a mediating effect of hopelessness the relationship between perceived stress and suicidal ideation in college students. For this study, a survey was conducted on perceived stress, suicidal ideation, and mental health, self-esteem, problem drinking, and stress among 103 college studentsin Gyeonggi do. The results of this study are as follows. It was found that COVID-19 correlated with perceived stress, hopelessness, and suicidal ideation of college students. The hopelessness completely mediated between perceived stress and suicidal thoughts of college students, which is consistent with previous studies. This study is meaningful in that it confirmed relationship between the perceived stress, hopelessness, and suicidal ideations in college students due to COVID-19, reflecting the new situation of the times. Coronavirus will worsen people's mental health disorders and cause new stress-related disorders. Therefore, mental health researchers, clinicians, and people working in trauma-related fields should find ways to reduce the incidence of coronavirus-related trauma stress and prevent its effects. It is necessary to expand the psychological vaccine program to improve the resilience of the public. Since there are individual differences in resilience, it is necessary to strengthen the psychological vaccine program for each subject considering resilience.